Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division — Atlanta, Georgia

Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division is a clinical research site located in Atlanta, Georgia, United States 31404.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hemophilia A With Inhibitor, Hemophilia B With Inhibitor.

Sponsors: American Thrombosis and Hemostasis Network.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division?

Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division conducted?

Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division has 1 clinical trials on record, with 1 currently active. Their work covers Hemophilia A With Inhibitor, Hemophilia B With Inhibitor.

Is Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division accredited by Crixeo Health?

Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.